Transaction

• In October 2009, Alpha Innotech Corp. was acquired by Cell Biosciences, Inc. Pursuant to the merger agreement announced on September 8, 2009, former Alpha Innotech stockholders received $1.50 per share, or approximately $17.9 million in cash.
• Seven Hills issued a fairness opinion to Alpha Innotech’s Board of Directors in connection with the transaction.

Companies

• Alpha Innotech Corp. is a leading developer, manufacturer, and marketer of digital imaging and analysis systems for the life science research and drug discovery markets. With 10,000 systems sold worldwide, the company offers a broad range of best-in-class products, from entry-level gel documentation systems to premier systems for multiplexed fluorescence and proteomics applications.
• Cell Biosciences, Inc. is a private life sciences company focused on nanoproteomics. It develops instrumentation systems, software, and assay products that reveal previously undetectable information about cellular control pathways.

Result

• Seven Hills issued a fairness opinion to the Board of Directors of Alpha Innotech in connection with the transaction.